| Product Code: ETC7630725 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Gastric Cancer Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Gastric Cancer Market - Industry Life Cycle |
3.4 Ireland Gastric Cancer Market - Porter's Five Forces |
3.5 Ireland Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Ireland Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Ireland Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Ireland Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Ireland Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Ireland Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in Ireland |
4.2.2 Technological advancements in diagnosis and treatment of gastric cancer |
4.2.3 Rising awareness about early detection and screening programs |
4.3 Market Restraints |
4.3.1 High cost of advanced treatments for gastric cancer |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Ireland |
5 Ireland Gastric Cancer Market Trends |
6 Ireland Gastric Cancer Market, By Types |
6.1 Ireland Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Ireland Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Ireland Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Ireland Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Ireland Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Ireland Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Ireland Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Ireland Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Ireland Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 Ireland Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Ireland Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 Ireland Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 Ireland Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Ireland Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 Ireland Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Ireland Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 Ireland Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Ireland Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Ireland Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 Ireland Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 Ireland Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 Ireland Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Ireland Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Ireland Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Ireland Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Ireland Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Ireland Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Ireland Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Ireland Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 Ireland Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Ireland Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Ireland Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Ireland Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Ireland Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 Ireland Gastric Cancer Market Import-Export Trade Statistics |
7.1 Ireland Gastric Cancer Market Export to Major Countries |
7.2 Ireland Gastric Cancer Market Imports from Major Countries |
8 Ireland Gastric Cancer Market Key Performance Indicators |
8.1 Survival rates of gastric cancer patients in Ireland |
8.2 Adoption rate of new diagnostic technologies in the market |
8.3 Number of healthcare facilities offering specialized gastric cancer treatments in Ireland |
8.4 Participation rate in gastric cancer screening programs |
8.5 Patient satisfaction with the quality of care received for gastric cancer in Ireland |
9 Ireland Gastric Cancer Market - Opportunity Assessment |
9.1 Ireland Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Ireland Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Ireland Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 Ireland Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Ireland Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Ireland Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Gastric Cancer Market - Competitive Landscape |
10.1 Ireland Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 Ireland Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here